Annual EBITDA
$1.21B$420.00M-25.80%
Summary
- Current Value
- As of today, SOLV annual EBITDA is $1.21B, down -25.80% on
- Historical Performance
- SOLV annual EBITDA is down -46.81% over the past 3 years, down -40.46% over the past 5 years
- All-Time High Comparison
- SOLV annual EBITDA is currently -51.21% below its historical high of $2.48B set on
- 3-Year Low Comparison
- SOLV annual EBITDA is at its 3-year low
- Sector Comparison
- SOLV annual EBITDA is higher than 93.84% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.21B | -25.8% | -46.8% | -40.5% | -40.5% | |
| Quarterly EBITDA | $302.00M | -8.8% | -43.5% | -46.5% | -46.5% | |
| TTM EBITDA | $1.52B | -7.0% | +38.4% | +169.4% | +169.4% | |
| Price | $66.15 | -10.6% | – | – | – | |
| PE Ratio | 7.45 | -72.2% | – | – | – | |
| Annual Revenue | $8.33B | +0.9% | +2.4% | +14.3% | +14.3% | |
| Annual EPS | $8.88 | +221.9% | +14.2% | +34.7% | +34.7% | |
| $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | ||
| Annual Net Income | $1.56B | +224.8% | +15.9% | +36.7% | +36.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.27B | N/A | -46.8% |
| 5Y | $2.48B | -51.2% | |
| All | $2.48B | -51.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.21B | at low | |
| 5Y | $1.21B | at low | |
| All | $1.21B | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $1.21B | -25.8% | |
| $1.63B | -27.7% | |
| $2.25B | -0.8% |
| Year | Value | Change |
|---|---|---|
| $2.27B | -8.3% | |
| $2.48B | +22.0% | |
| $2.03B | - |
FAQ
What is the current annual EBITDA of SOLV?
As of today, SOLV annual EBITDA is $1.21B
What is 1-year change in SOLV annual EBITDA?
SOLV annual EBITDA is down -25.80% year-over-year
What is 3-year change in SOLV annual EBITDA?
SOLV annual EBITDA is down -46.81% over the past 3 years
How far is SOLV annual EBITDA from its all-time high?
SOLV annual EBITDA is currently -51.21% below its historical high of $2.48B set on December 1, 2021
How does SOLV annual EBITDA rank versus sector peers?
SOLV annual EBITDA is higher than 93.84% of companies in Healthcare sector
When is SOLV next annual earnings release?
As of today, the next annual earnings release for SOLV has not been scheduled
Quarterly EBITDA
$302.00M$17.00M+5.96%
Summary
- Current Value
- As of today, SOLV quarterly EBITDA is $302.00M, up +5.96% on
- Historical Performance
- SOLV quarterly EBITDA is down -8.76% year-over-year, down -43.55% over the past 3 years
- All-Time High Comparison
- SOLV quarterly EBITDA is currently -53.40% below its historical high of $648.00M set on
- 3-Year Low Comparison
- SOLV quarterly EBITDA is +5.96% above its 3-year low of $285.00M reached on
- Sector Comparison
- SOLV quarterly EBITDA is higher than 93.33% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $302.00M | +6.0% | -8.8% | -43.5% | -46.5% | |
| Annual EBITDA | $1.21B | – | -25.8% | -46.8% | -40.5% | |
| TTM EBITDA | $1.52B | -1.9% | -7.0% | +38.4% | +169.4% | |
| Price | $66.15 | -20.3% | -10.6% | – | – | |
| PE Ratio | 7.45 | -22.0% | -72.2% | – | – | |
| Quarterly Revenue | $2.00B | -4.7% | -3.7% | -0.3% | -0.6% | |
| Quarterly EPS | $0.36 | -95.0% | +108.6% | -79.8% | -81.5% | |
| $191.00M | +11.7% | +4.4% | -50.3% | -54.9% | ||
| Quarterly Net Income | $63.00M | -95.0% | +110.0% | -79.5% | -81.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $622.00M | -51.5% | |
| 3Y | $648.00M | -53.4% | |
| 5Y | $648.00M | -53.4% | |
| All | $648.00M | -53.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $285.00M | +6.0% | |
| 3Y | $285.00M | +6.0% | |
| 5Y | $285.00M | +6.0% | |
| All | $285.00M | +6.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of SOLV?
As of today, SOLV quarterly EBITDA is $302.00M
What is SOLV quarterly EBITDA most recent change?
SOLV quarterly EBITDA was up +5.96% on December 31, 2025
What is 1-year change in SOLV quarterly EBITDA?
SOLV quarterly EBITDA is down -8.76% year-over-year
How far is SOLV quarterly EBITDA from its all-time high?
SOLV quarterly EBITDA is currently -53.40% below its historical high of $648.00M set on September 30, 2023
How does SOLV quarterly EBITDA rank versus sector peers?
SOLV quarterly EBITDA is higher than 93.33% of companies in Healthcare sector
When is SOLV next earnings release?
The next earnings release for SOLV is on
TTM EBITDA
$1.52B$29.00M-1.87%
Summary
- Current Value
- As of today, SOLV TTM EBITDA is $1.52B, down -1.87% on
- Historical Performance
- SOLV TTM EBITDA is down -6.97% year-over-year, up +38.36% over the past 3 years
- All-Time High Comparison
- SOLV TTM EBITDA is currently -32.74% below its historical high of $2.26B set on
- 3-Year Low Comparison
- SOLV TTM EBITDA is +6.51% above its 3-year low of $1.43B reached on
- Sector Comparison
- SOLV TTM EBITDA is higher than 94.52% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.52B | -1.9% | -7.0% | +38.4% | +169.4% | |
| Annual EBITDA | $1.21B | – | -25.8% | -46.8% | -40.5% | |
| Quarterly EBITDA | $302.00M | +6.0% | -8.8% | -43.5% | -46.5% | |
| Price | $66.15 | -20.3% | -10.6% | – | – | |
| PE Ratio | 7.45 | -22.0% | -72.2% | – | – | |
| TTM Revenue | $8.35B | -0.9% | +1.1% | +108.0% | +315.5% | |
| TTM EPS | $8.87 | +2.1% | +221.7% | +138.7% | +357.5% | |
| $1.05B | +0.8% | -3.4% | +29.6% | +147.3% | ||
| TTM Net Income | $1.56B | +2.2% | +225.5% | +142.4% | +364.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.67B | -9.1% | |
| 3Y | $2.26B | -32.7% | |
| 5Y | $2.26B | -32.7% | |
| All | $2.26B | -32.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.43B | +6.5% | |
| 3Y | $1.43B | +6.5% | |
| 5Y | $565.00M | +169.4% | |
| All | $565.00M | +169.4% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of SOLV?
As of today, SOLV TTM EBITDA is $1.52B
What is SOLV TTM EBITDA most recent change?
SOLV TTM EBITDA was down -1.87% on December 31, 2025
What is 1-year change in SOLV TTM EBITDA?
SOLV TTM EBITDA is down -6.97% year-over-year
How far is SOLV TTM EBITDA from its all-time high?
SOLV TTM EBITDA is currently -32.74% below its historical high of $2.26B set on March 31, 2024
How does SOLV TTM EBITDA rank versus sector peers?
SOLV TTM EBITDA is higher than 94.52% of companies in Healthcare sector
When is SOLV next earnings release?
The next earnings release for SOLV is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- SOLV Official Website www.solventum.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.htm
- SOLV Profile on Yahoo Finance finance.yahoo.com/quote/SOLV
- SOLV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/solv